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Interferon-antagonistin is a multifunctional virulence factor. Here, we report a crystal structure for the
NS1 effector domain of avian inﬂuenza virus A/Duck/Albany/76. Comparison of this structure with that
reported for a human strain shows both proteins share a common monomer conformation, albeit with subtle
differences. Strikingly, our data reveal a novel helix–helix dimeric interface between monomers of the avian
NS1 protein, which is also found in the human NS1 crystal lattice. We re-evaluate the current model of NS1
dimeric assembly, and provide biochemical evidence to show tryptophan-187 (a residue located at the helix–
helix interface) is essential for dimerization of this effector domain.
© 2008 Elsevier Inc. All rights reserved.IntroductionIn infected cells, the inﬂuenza A virus non-structural (NS1) protein
contributes to efﬁcient virus replication by participating in multiple
protein-RNA and protein-protein interactions. The N-terminal 73
amino-acids of NS1 form a symmetrical homodimeric RNA-binding
domain (Yin et al., 2007), which is functionally implicated in the
inhibition of both interferon (IFN) induction (Donelan et al., 2003), and
the antiviral effects of IFN (Min and Krug, 2006). The remaining 157
amino-acids of NS1 (residues 74–230; termed the effector domain), bind
a plethora of host-cell proteins in order to carry out various functions: (i)
enhancementof viralmRNA translation (Burgui et al., 2003); (ii) deregu-
lation of cellular mRNA processing (Noah et al., 2003); (iii) inhibition of
dsRNA-activated protein kinase (PKR) (Li et al., 2006); and (iv) activation
of phosphoinositide 3-kinase (PI3K) signaling (Hale et al., 2006).
It is becoming increasingly apparent that themechanisms bywhich
NS1 acts may be strain speciﬁc (Hayman et al., 2006; Kochs et al.,
2007). Furthermore, a number of sequence and functional differences
between human and avian NS1 protein effector domains have recently
been described (Heikkinen et al., 2008; Obenauer et al., 2006). Here, in
an attempt to structurally understand some of this strain variation, we
have determined the X-ray crystallographic structure of an avian in-
ﬂuenza A virus NS1 protein effector domain, and compared it with the
previously published human inﬂuenza A virus NS1 effector domain
structure (Bornholdt and Prasad, 2006).ces, University of St. Andrews,
.
l rights reserved.Results and discussion
The NS1 effector domain (residues 73–230) of avian inﬂuenza virus
A/Duck/Albany/76 [H12N5; NS allele B] (Alb/NS1Δ72) was expressed
and puriﬁed from E. coli. Gel ﬁltration conﬁrmed that untagged Alb/
NS1Δ72 protein is likely to be homodimeric in solution (data not shown,
see also Fig. 2B), an observation consistent with results recently
obtained using the NS1 effector domain of human inﬂuenza virus A/
Puerto Rico/8/34 [H1N1; NS allele A] (PR8/NS1Δ72) (Bornholdt and
Prasad, 2006). Alb/NS1Δ72 was crystallized, and its dimeric structure
solved by molecular replacement to 2.0 Å resolution (Table 1).
The monomer
Structural comparison of Alb/NS1Δ72 with the published 2.1 Å
resolution PR8/NS1Δ72 structure (Bornholdt and Prasad, 2006),
revealed the overall conformation of both human and avian protein
monomers to be highly similar (root mean square deviation of 0.9 Å
for 101 Cα atoms). The most conspicuous structural difference
between Alb/NS1Δ72 and PR8/NS1Δ72 monomers is in the orienta-
tion of the β-hairpin (herein referred to as the 140-loop) between the
fourth and ﬁfth β-strands (Alb/NS1 residues 135–143) (Fig. 1A). The
140-loop is involved in crystal packing for only one monomer of the
dimer but adopts the same conformation in both monomers, and
therefore the difference in orientation is not as a result of crystal
packing. A precise biological role for the 140-loop has yet to be
determined. However, residues within and adjacent to this loop have
previously been implicated in mediating the nuclear export of NS1
into the cytoplasm of infected cells (Li et al., 1998). Although NS1
Fig. 1. Cartoon representations of the Alb/NS1Δ72 and PR8/NS1Δ72 structures. (A)
Superposition of the Alb/NS1Δ72 (green) and PR8/NS1Δ72 (yellow) monomers.
Selected residues are shown as sticks. (B) The Alb/NS1Δ72 helix–helix dimer with the
two monomers coloured green and gold. Residues are highlighted as for (A). (C)
Superposition of the Alb/NS1Δ72 (green and gold monomers) and PR8/NS1Δ72 (yellow
and cyan monomers) helix–helix dimers. Structural conservation of Trp-187 at the
dimer interface is highlighted.
Table 1
Crystallographic statistics
Space group P6522
Unit cell dimensions (Å) a=65.25, b=65.25, c=338.77
Resolution (Å) 2.0 (2.03–2.00)
Rsym (%) 3.8 (16.0)
I/σI 70.0 (7.5)
Completeness (%) 85.9 (49.0)
Unique reﬂections 26147
Redundancy 8.3
Rwork (%) 18.3
Rfree (%) 22.4
Protein atoms 1904
Water atoms 387
Rmsd bonds (Å) 0.007
Rmsd angles (°) 1.07
Values in parentheses refer to the highest resolution shell. Rsym=∑ j|〈I〉− Ij|/∑〈I〉, where Ij
is the intensity of the jth reﬂection, and 〈I〉 is the average intensity. Rwork=∑||Fo|− |Fc||/∑|
Fo|. Rfree=∑ T||Fo|− |Fc||/∑ T |Fo|, where T is a test data set of 5% of the total reﬂections
randomly chosen and set aside before reﬁnement.
2 Rapid Communicationproteins from different virus strains can exhibit varying cellular
localization patterns during infection (Hayman et al., 2006), it is
currently unknown if this is due to 140-loop variation. Without
determining the structures of more NS1 effector domains, it is im-
possible to say whether the different 140-loop structures are generally
conserved between human and avian virus isolates, or even between
allele A and allele B NS segments.
Comparison of the Alb/NS1Δ72 and PR8/NS1Δ72 monomers also
revealed variation in the orientation of two highly conserved residues
reported to be necessary for the interaction of NS1 with cellular
proteins. Tyr-89 is essential for the NS1-mediated binding and
activation of PI3K (Hale et al., 2006), yet appears to adopt a different
conformation in each effector domain structure (Fig. 1A). Despite this,
both full-length PR8 and Alb NS1 proteins efﬁciently interact with the
p85β subunit of PI3K (B.G. Hale, unpublished data). Trp-187, which
has been implicated in binding of NS1 to the 30 kDa subunit of
cleavage and polyadenylation speciﬁcity factor (CPSF30) (Noah et al.,
2003), also adopts a different orientation within each structure (Fig.
1A). Although PR8/NS1 does not interact with CPSF30 (Kochs et al.,
2007), the ability of Alb/NS1 to efﬁciently limit gene expression from
an IFN-inducible promoter suggests that the CPSF30-binding site on
Alb/NS1 is functional (Hayman et al., 2007). As discussed below, the
orientation of Trp-187 may actually inﬂuence the precise dimeric
assembly of Alb/NS1Δ72, rather than be directly involved in binding
CPSF30.
The dimer interface
The previously reported dimeric interface of PR8/NS1Δ72 is
formed by interactions between the ﬁrst N-terminal β-strands of
each monomer (strand–strand dimer), resulting in a contiguous
twisted anti-parallel β-sheet ﬂanked by long α-helices on either end
of the dimer (Bornholdt and Prasad, 2006). However, results from our
Alb/NS1Δ72 structure have prompted us to re-evaluate this model of
NS1 effector domain dimerization. Alb/NS1Δ72 crystallizes in space
group P6522, and contains two monomers in the asymmetric unit.
Two possible dimers are observed, neither of which resemble the
previously reported PR8/NS1Δ72 dimer. Of the two observable di-
mers, one is formed by interactions between the two long α-helices
(helix–helix dimer), whilst the other is formed by the loops
preceding the long α-helices (loop–loop dimer). As the helix–helix
dimer interface buries the most surface area (584 Å2), it is likely that
this is the dimer observed in solution (Fig. 1B). Indeed, inspection of
crystal packing in the published PR8/NS1Δ72 unit cell (Bornholdt and
Prasad, 2006), revealed that the helix–helix dimer is also present in
this crystal lattice via application of the crystallographic symmetryoperation x−1, y, z (PDB ID: 2GX9). It should be noted that the
alternative loop–loop dimer found in the Alb/NS1Δ72 asymmetric
unit is not observed in the published PR8/NS1Δ72 crystal lattice.
Superposition of the Alb/NS1Δ72 and possible PR8/NS1Δ72 helix–
helix dimers show that orientation of the twomonomers with respect
to one another is slightly different between strains (Fig.1C). Given that
Trp-187 is found at the helix–helix interface and adopts a different
rotamer in Alb as compared with PR8 (Figs. 1A and C), it may be that
orientation of this residue is partially responsible for the observed
variation in monomer–monomer positioning. Whether such variation
also occurs in the context of a full-length NS1 protein, or has func-
tional consequences with respect to strain-speciﬁc differences, has yet
to be determined.
Trp-187 is essential for effector domain dimerization
To conﬁrm that a helix–helix conformation is indeed the true
dimeric state of Alb/NS1Δ72 in solution, we puriﬁed a panel of mutant
Fig. 2. Trp-187 is essential for Alb/NS1Δ72 dimerization (A) Structural location of Trp-187 in both the helix-helix dimer and the strand-strand dimer conformation of PR8/NS1Δ72.
Note that Trp-187 only participates in the interface of the helix–helix dimer. (B) Gel ﬁltration analysis of the puriﬁedWTandmutant 6His-tagged Alb/NS1Δ72 proteins. (C) Estimation
of protein multimeric states based upon gel ﬁltration data. Ve is the elution volume, and Kav is the gel-phase distribution coefﬁcient. Calibration of the column determined the
relationship between Kav and Mr as: Kav=−0.217ln(Mr)+2.5099. Full values were used in all calculations, but were rounded to the nearest 2 decimal places for tabulation. (D) SDS-
PAGE analysis, and (E) CD spectroscopy, of the WT and mutant proteins. For (D), molecular weight markers (kDa) are indicated to the right.
3Rapid Communication6His-tagged Alb/NS1Δ72 proteins and estimated their multimeric
state by analytical gel ﬁltration. Residues for substitutionwere chosen
based upon their location at or near the helix–helix interface, and
which were not involved in any possible loop–loop or strand–strand
interface: Met-106, Gln-121, and Trp-187 (Figs. 1A, B, and 2A). Both
Met-106 (M106A) and Gln-121 (Q121A) mutant proteins, like WT,
appeared to be homodimeric, whilst the Trp-187 (W187A) mutant
eluted in a volume consistent with it being a monomer (Figs. 2B and
C). SDS-PAGE analysis revealed that the denatured monomeric WT
andmutant polypeptides all exhibited identical mobility (Fig. 2D), andcircular dichroism (CD) spectroscopy conﬁrmed that the proteins had
a similar secondary structure (Fig. 2E). Thus, all these Alb/NS1Δ72
mutants folded correctly. The data therefore indicate that substitution
of alanine for tryptophan at residue 187 in Alb/NS1Δ72 speciﬁcally
disrupts dimerization of this domain. Although Met-106 and Gln-121
are also at the helix–helix dimer interface, individual mutation of
these residues alone is insufﬁcient to prevent dimerization. Instead, it
appears that reciprocal packing of Trp-187 into a hydrophobic pocket
found in the adjacent monomer is most critical for Alb/NS1Δ72
dimeric assembly.
Fig. 3. The ﬂexible C-terminus of Alb/NS1Δ72. (A) 2Fo–Fc electron density map
(contoured at 1σ) for residues Gln-218 to Arg-224. (B) The Alb/NS1Δ72 helix–helix
dimer highlighting the location of the peptide consisting of residues Gln-218 to Arg-
224. A known SH3-binding peptide (cyan) was positioned adjacent to Gln-218 to
demonstrate that the distance spanned by the unobserved residues is physically
possible.
4 Rapid CommunicationGiven that dimerization of the NS1 effector domain may be
essential for IFN-antagonistic properties of the RNA-binding domain
(Wang et al., 2002), it is worth noting that Trp-187 is wholly conserved
among all inﬂuenza A viruses sequenced to date. Many other of the
amino acids in this region are also highly conserved, a common
feature of true dimer interfaces. Five residues previously shown to be
necessary for the interaction of NS1 with CPSF30 are also located at
the helix–helix dimer interface of the avian NS1 effector domain: Gly-
184, Leu-185, Glu-186, Trp-187, and Asn-188 (Noah et al., 2003). As
mutation of all these residues (particularly Trp-187) likely prevents
dimerization of this domain, it is possible that CPSF30-binding
depends upon a fully intact NS1 dimer. These observations highlight
the structural importance of Trp-187 for functional integrity of NS1.
The “disordered tail” of NS1
Despite their presence in the original constructs, residues down-
stream of Ala-202 or Asn-207 were not readily observed in either our
Alb/NS1Δ72 structure or the published PR8/NS1Δ72 structure,
respectively. The structure and functions of this region of NS1 are
intriguing. NS1 proteins from a number of naturally isolated strains
have previously been described that either lack up to ~20 residues of
this “tail”, or which have a 7 amino-acid extension (Suarez and Perdue,
1998). In addition, a number of functions have been ascribed to this
region in avian NS1 proteins that are lacking in human NS1 proteins.
For example, avian (but not human) NS1 proteins contain a consensus
Src homology 3 (SH3) domain-binding motif at residues 212–215,
which can interact with human Crk/CrkL proteins to enhance cellular
PI3K activation (Heikkinen et al., 2008). Furthermore, the four C-
terminal residues of most avian NS1 proteins form a putative PDZ
domain ligand (Obenauer et al., 2006), and these residues of NS1
clearly modulate virus pathogenicity in mice (Jackson et al., 2008).
Mass spectrometric analysis of our puriﬁed Alb/NS1Δ72 protein in
solution revealed the presence of two polypeptide species, the masses
of which correlated best with predicted masses for both the full-
length Alb/NS1Δ72 protein and an N-terminal eight amino-acid
truncation (up to residue Glu-75) (data not shown). Thus, our inability
to resolve amino-acids beyond Ala-202 is unlikely to be due to a
deletion at the C-terminus, but is consistent with intrinsic protein
disorder in this region. However, as the reﬁnement progressed, it was
clear that there was a linear stretch of difference density, reminiscent
of a short peptide, packing against a symmetry related monomer.
Closer inspection of the difference map clearly revealed a tyrosine
residue in the centre, spanned by two large amino acids. The C-
terminus of Alb/NS1Δ72 contains only a single tyrosine residue, which
is in the sequence Arg-Tyr-Met. The direction of the chain was
determined by the presence of density for a small side chain after Met-
222, and for a large side chain prior to Arg-220.Wewere ﬁnally able to
build in 7 amino-acids from this “disordered tail” (Gln-218 to Arg-224)
(Fig. 3A). Given that the sequence before Gln-218 contains a consensus
SH3 domain-binding motif (Heikkinen et al., 2008), we simply placed
the structure of a known SH3-binding peptide adjacent to Gln-218 in
order to conﬁrm that the distance spanned between Ala-202 and Gln-
218 of the modelled structure is physically possible (Fig. 3B). The
precise conformation of the observed 7 amino-acid stretch of the C-
terminus of Alb/NS1 is probably determined by its participation in
crystal packing interactions, but it does conﬁrm that the C-terminal
“disordered tail” of Alb/NS1Δ72 is indeed still present within the
crystal, and that there is a high degree of intrinsic ﬂexibility within
this region. It may be that disorder-to-order transitions occur in the
“tail” upon binding the appropriate ligand.
Concluding remarks
It is often difﬁcult to discriminate between a biologically relevant
interface and crystal-packing interfaces in crystal lattices. In thepreviously published crystal structure of the PR8/NS1 effector domain,
the authors logically chose the dimer interface (i.e. the strand–strand
dimer) that buried themost surface area (Bornholdt and Prasad, 2006).
Wewere unable to observe this dimeric state in the asymmetric unit of
the Alb/NS1Δ72 crystals. From our data we suggest that a helix–helix
interface may be the most biologically relevant dimer for NS1Δ72,
given that it is observed in the crystal lattices of both PR8 and Alb
proteins. Our biochemical studies also support this hypothesis, as
substitution of alanine for tryptophan at residue 187 prevented Alb/
NS1Δ72 dimer formation. However, we cannot exclude the possibility
that there are functional roles for both dimeric states, which occur in
either a strain-speciﬁc or ligand-dependent manner. Thus, NS1
proteins may exhibit variation in their dimeric assemblies, a property
that could contribute to their apparent multifunctional nature. It
should also be noted that dimerization of the isolated NS1 protein
effector domain may differ from that observed in the full-length NS1
protein, whose overall multimerization is inﬂuenced by both the RNA-
binding and effector domains (Nemeroff et al., 1995).
The structure of an avian inﬂuenza A virus NS1 protein effector
domain presented here provides additional insights into the strain-
speciﬁc nature of this important virulence factor. Such data may serve
as a starting point for the interpretation of mutational analyses, or for
the rational design of antiviral compounds.
Materials and methods
Plasmid construction
cDNA encoding residues 73–230 from the NS1 protein of inﬂuenza
virus strain A/Duck/Albany/76 (H12N5; Alb) was ampliﬁed by PCR
5Rapid Communicationfrom an existing NS1 clone (Hayman et al., 2007), and ligated between
the EcoRI and NotI sites of a modiﬁed pRSFDuet-1 vector (Novagen).
Four-primer overlap PCR was used to introduce speciﬁc site-directed
point mutations into the Alb/NS1Δ72 cDNA. The integrity of each
construct was conﬁrmed by DNA sequencing.
Protein expression and puriﬁcation
Recombinant 6His-tagged NS1Δ72 was expressed in E. coli strain
BL-21 (DE3). Cultures were grown at 30 °C to an OD600 of 0.4–0.6, and
protein expressionwas induced by addition of 1 mM IPTG for a further
4 h at 30 °C. Freeze-thawed cell pellets were resuspended in buffer A
(50 mM Tris–HCl [pH 7.8], 0.2 M NaCl) supplemented with 10 mM
imidazole and appropriate protease inhibitors, and disrupted by
sonication. The crude lysate was initially clariﬁed by centrifugation at
15,000 ×g for 30 min, followed by ﬁltration through a 0.22 μm ﬁlter.
Cleared lysate was loaded onto a pre-equilibrated 5 mL HiTrap Ni-NTA
column (GE Healthcare) and washed extensively with buffer A
supplemented with 10 mM imidazole. 6His-tagged proteins were
then eluted on an imidazole gradient, and 6His-tagged TEV protease
was added to the protein at a 50:1 (TEV:target protein) mass ratio. The
cleavage reaction was incubated for 20 h at room temperature whilst
dialyzing in buffer A supplemented with 5 mM β-mercaptoethanol.
Cleaved NS1Δ72 was separated from 6His-tagged NS1Δ72 and 6His-
tagged TEV protease by difference puriﬁcation on a 5 mL HiTrap Ni-
NTA column. The protein was then polished by size-exclusion chro-
matography on a pre-calibrated HiLoad 16/60 Superdex 75 gel
ﬁltration column (GE Healthcare) equilibrated and eluted with buffer
A. The puriﬁed proteinwas concentrated, and further characterized by
SDS-PAGE or mass spectrometry.
Protein crystallization, data collection, and structure solution/reﬁnement
WT Alb/NS1Δ72 crystals were obtained by vapor diffusion in
hanging drops consisting of 2 μl reservoir solution (0.1 M HEPES [pH
7.0], 1 M ammonium sulfate, 0.2 M sodium thiocyanate, 0.5% PEG
8000, 20% glycerol) and 2 μl concentrated protein solution (~9 mg/mL
in buffer A). Data were collected on an in-house rotating anode (RA
Micro7 HFM) and a Saturn944 CCD at 100 K and processed with
HKL2000 (Otwinowski andMinor, 1993). The data have low complete-
ness in the highest resolution bins due to large c-axis of the crystals,
but are highly signiﬁcant and redundant to 2.0 Å. The structure was
solved by molecular replacement using the program PHASER (McCoy
et al., 2007) and reﬁned using Refmac5 (CCP4, 1994) or PHENIX
(Adams et al., 2002) with manual model building using O (Jones et al.,
1991). Figs. 1, 2A, and 3 were created using PyMol.
Circular dichroism (CD) spectroscopy
Comparative secondary structure CD analyses of WT and mutant
6His-tagged Alb/NS1Δ72 proteins were performed using a Jasco J-810
spectropolarimeter. Each proteinwas diluted to ~0.15 mg/mL in buffer
B (10 mM Tris–HCl [pH 7.8], 150 mMNaF), and measured between 190
and 260 nm.
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